Hybrid Closed-Loop Therapy Effective for Pregnant Women With Type 1 Diabetes

Results from the AiDAPT trial show hybrid closed-loop therapy significantly improves maternal glycemic control during pregnancy complicated by T1D.

Related Keywords

United Kingdom ,Vitalii Vodolazskyi ,Helen Murphy ,Polskys Technology ,University Of East Anglia ,Norwich Medical School ,Diabetes Meeting ,Type 1 Diabetes ,T1d ,